Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00588640 · ClinicalTrials.gov registry record · Phase 1

Study of D-Methadone in Patients With Chronic Pain

A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target

NCT00588640: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00588640 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00588640, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to determine the safest dose of d-methadone that can be given, without causing severe side effects in most patients with chronic pain. Patients are being asked to participate in the Phase I portion of this study.

Primary Outcome

The number of patients who reached a safe and well tolerated dose of d-methadone

Interventions

  • DRUG placebo
  • DRUG d-Methadone
  • DRUG D-methadone

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2004-10
Est. Completion 2008-07
Phase Phase 1
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00588640 record still lists

NCT00588640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.

NCT00588640 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00588640 about?

NCT00588640 is a clinical study titled "Study of D-Methadone in Patients With Chronic Pain". The purpose of this study is to determine the safest dose of d-methadone that can be given, without causing severe side effects in most patients with chronic pain. Patients are being asked to participate in the Phase I portion of this study.

What is the current status of trial NCT00588640?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2004-10. Estimated completion is 2008-07.

What interventions are being tested in trial NCT00588640?

The interventions under investigation include: placebo (DRUG), d-Methadone (DRUG), D-methadone (DRUG).

Who is sponsoring clinical trial NCT00588640?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00588640's enrollment target sits among peer trials

10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00588640, the US trial registry maintained by the National Library of Medicine. NCT00588640 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.